The suzetrigine, which only acts on pain neurons, is the first innovation in analgesia in the last 20 years. "It stands out ...

For the first time in more than 25 years, the U.S. Food and Drug Administration has signed off on a new type of pain reliever ...

but it does bridge the gap between no opioid, a weak opioid, and strong opioid,” he said. “This is something in-between that can be applicable for a large number of patients.” ...

Doctors from the Cleveland Clinic talk about how this new non-opioid pain medication could help reduce the issue of opioid ...

Geriatrics and Aging. 2009;12(1):48-52. Transdermal fentanyl may be used for patients who do not tolerate the orally available opioids or who cannot swallow sustained-release formulations.

For the first time in two decades, the Food and Drug Administration (FDA) has approved a new class of medication that provides an alternative to addictive opioids for patients looking to manage ...